Circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with incisional hernia

被引:20
|
作者
Henriksen, Nadia A. [1 ]
Sorensen, Lars T. [1 ]
Jorgensen, Lars N. [1 ,3 ]
Agren, Magnus S. [1 ,2 ,3 ]
机构
[1] Bispebjerg Hosp, Dept Surg K, DK-2400 Copenhagen NV, Denmark
[2] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen NV, Denmark
[3] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark
关键词
ABDOMINAL AORTIC-ANEURYSM; SKIN; STROMELYSIN; ACTIVATION; DISEASE; MARKER; SERUM; TIMPS;
D O I
10.1111/wrr.12071
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Incisional hernia formation is a common complication to laparotomy and possibly associated with alterations in connective tissue metabolism. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are closely involved in the metabolism of the extracellular matrix. Our aim was to study serum levels of multiple MMPs and TIMPs in patients with and without incisional hernia. Out of 305 patients who underwent laparotomy, 79 (25.9%) developed incisional hernia over a median follow-up period of 3.7 years. Pooled sera from a subset (n=72) of these patients were screened for MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-12, MMP-13, TIMP-1, TIMP-2, and TIMP-4 using a multiplex sandwich fluorescent immunoassay supplemented with gelatin zymography. The screening indicated differences in serum MMP-9 and TIMP-1 levels. Consequently, MMP-9 and TIMP-1 levels were measured in serum in the whole patient cohort with enzyme-linked immunosorbent assay. There were no significant differences in either MMP-9 (p=0.411) or TIMP-1 (p=0.679) levels between hernia and hernia-free patients. MMP-9 was significantly increased in smokers compared with nonsmokers (p=0.016). In conclusion, a possible involvement of MMPs and TIMPs in the pathogenesis of incisional hernia formation was not reflected systemically.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 50 条
  • [1] Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
    Tanaka, Komei
    Essick, Eric E.
    Connors, Lawreen H.
    Seldin, David C.
    Sam, Flora
    [J]. CIRCULATION, 2011, 124 (21)
  • [2] Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
    Tanaka, Komei
    Essick, Eric E.
    Doros, Gheorghe
    Tanriverdi, Kahraman
    Connors, Lawreen H.
    Seldin, David C.
    Sam, Flora
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02): : e005868
  • [3] Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection
    Shukla V.
    Shakya A.K.
    Shukla M.
    Kumari N.
    Krishnani N.
    Dhole T.N.
    Misra U.K.
    [J]. VirusDisease, 2016, 27 (1) : 63 - 76
  • [4] Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases levels in pediatric patients with congenital heart disease: Relationship to cardiac functions
    Kilic, Zubeyir
    Ucar, Birsen
    Ozdemir, Gokmen
    Colak, Omer
    Bal, Cengiz
    Ertugrul, Turkan
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (06): : 531 - 541
  • [5] Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure
    Tousoulis, Dimitris
    Andreou, Ioannis
    Tentolouris, Costas
    Antoniades, Charalambos
    Papageorgiou, Nikolaos
    Gounari, Panagiota
    Kotrogiannis, Iason
    Miliou, Antigoni
    Charakida, Marietta
    Trikas, Athanasios
    Stefanadis, Christodoulos
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (03) : 438 - 443
  • [6] Expression of Tissue Levels of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Gastric Adenocarcinoma
    Zhang, Ming
    Zhu, Guan-Yu
    Gao, Hong-Yu
    Zhao, Shu-Peng
    Xue, Yingwei
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (03) : 243 - 247
  • [7] Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood
    Mannello, Ferdinando
    Jung, Klaus
    Tonti, Gaetana A.
    Canestrari, Franco
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (18) : 1466 - 1473
  • [8] Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
    Zhen-kui Qiao
    Yan-long Li
    Hong-tao Lu
    Ke-liang Wang
    Wan-hai Xu
    [J]. World Journal of Surgical Oncology, 11
  • [9] Clinical Significance of Tissue Levels of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Gastric Cancer
    Shim, Ki-Nam
    Jung, Sung-Ae
    Joo, Yang-Hee
    Yoo, Kwon
    [J]. EWHA MEDICAL JOURNAL, 2005, 28 (02): : 59 - 67
  • [10] Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer
    Shim, Ki-Nam
    Jung, Sung-Ae
    Joo, Yang-Hee
    Yoo, Kwon
    [J]. JOURNAL OF GASTROENTEROLOGY, 2007, 42 (02) : 120 - 128